In principle, the current understanding of the impact of Se on cancer risk, if any in humans, suggests that it is largely mediated via the influence of Se status on the expression of selenoproteins, with different selenoproteins having different saturation plasma/serum Se thresholds [30]. The gene discussed is SELENOS; the disease is cancer.